In Ovo Administration of Silver Nanoparticles Enhances Post-Hatch Growth Performance, Metabolic and Physiological Responses, and Immune Function in Broiler Chickens

This study examined the effects of in ovo silver nanoparticle (AgNP) administration on broiler chicken hatchability, growth performance, physiological and metabolic status, antioxidant capacity, and immune responses. A total of 300 fertilized Cobb500 eggs were assigned to five treatments (5 replicates/treatment, 12 eggs/replicate): non-injected control; vehicle control (0.2 mL sterile 0.9% NaCl/egg); and AgNPs at 10, 15, or 20 ppm injected into their amniotic sac on day (d) 18 of incubation. After hatching, 48 chicks/treatment were assigned to 6 replicate cages (8 birds/replicate) for 35 d. In ovo AgNP administration improved hatchability and reduced embryonic mortality (p < 0.05). Post-hatch, birds originating from AgNP-injected eggs had an improved body weight, body weight gain, and feed conversion ratio, with lower feed intake (p < 0.05). AgNP administration elevated hemoglobin, packed cell volume, growth hormone, serum proteins, alanine aminotransferase activity, and creatinine levels (p < 0.05). AgNPs also improved the lipid profile and increased total antioxidant capacity, catalase and superoxide dismutase activities, lysozyme activity, complement 3, and cytokine concentrations and reduced malondialdehyde levels (p < 0.05). Effects were dose-dependent, with 15 ppm generally leading to better outcomes. These findings suggest that 15 ppm AgNP in ovo administration enhances embryonic viability, physiological resilience, and post-hatch performance in broiler chickens.